Search

everythinglearnresearchcommunity

for

Search:↓

The study found that prescribing patterns for Cyproterone Acetate/Ethinylestradiol in Italy did not significantly change after EMA recommendations.

PRP therapy is effective and safe for skin conditions like wound healing and hair loss.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

JAGGED1 could help regenerate tissues for bone loss and heart damage if delivered correctly.

StemMACS media is better for growing therapeutic stem cells.

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

South Asian women with PCOS present with different symptoms compared to White women, influenced by ethnicity, obesity, and age.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

Cooling the skin before injections reduces pain for patients with hair loss.

The document covers various dermatological treatments and conditions.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

COVID-19 may harm male fertility and damage the reproductive system.

The length of CAG repeats in the androgen receptor gene is linked to ovarian reserve but does not affect how the ovaries respond to stimulation.

New acne treatments include combination creams, advanced retinoids, and light therapies, focusing on safety and patient adherence.

Adaptive coping reduces PCOS symptoms, while maladaptive coping worsens them.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

Artificial skin development has challenges, but new materials and understanding cell behavior could improve tissue repair. Also, certain growth factors and hydrogel technology show promise for advanced skin replacement therapies.

Asia has made significant progress in tissue engineering and regenerative medicine, but wider clinical use requires more development.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

The document concludes that minoxidil and finasteride are proven for hair growth, herbal remedies show promise, but more research is needed to confirm their effectiveness.